πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11786582

Human application of engineered chimeric antigen receptor (CAR) T-cells

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11786500

Glutaminase inhibitor therapy

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11780879

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

The Board of Regents of the University of Texas System Β· Granted Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11766408

Compositions and methods for organ specific delivery of nucleic acids

The Board of Regents of the University of Texas System Β· Granted Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11766402

Methods for production of MSC-derived exosomes

The Board of Regents of the University of Texas System Β· Granted Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11760799

Leptin antibodies

The Board of Regents of the University of Texas System Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11759427

Formation of stable submicron peptide or protein particles by thin film freezing

The Board of Regents of the University of Texas System Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11760858

Dendritic macroporous hydrogels prepared by crystal templating

The Board of Regents of the University of Texas System Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11753381

Inhibitors of receptor interacting protein kinase I for the treatment of disease

The Board of Regents of the University of Texas System Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11753655

Compositions and methods for treatment of neurological disorders

The Board of Regents of the University of Texas System Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11744926

Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applicati

The Board of Regents of the University of Texas System Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11746152

Methods of cancer treatment and therapy using a combination of antibodies that bind glycos

The Board of Regents of the University of Texas System Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11738053

Methods and compositions for treating chronic granulomatous disease

The Board of Regents of the University of Texas System Β· Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11738119

Antimicrobial catheters

The Board of Regents of the University of Texas System Β· Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11730801

Live attenuated Zika virus with 3'UTR deletion, vaccine containing and use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11725008

Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

The Board of Regents of the University of Texas System Β· Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11723990

Library of pH responsive polymers and nanoprobes thereof

The Board of Regents of the University of Texas System Β· Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11723992

Method for extraction and purification of 68GA

The Board of Regents of the University of Texas System Β· Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11723864

Antimicrobial and anti-inflammatory compositions

The Board of Regents of the University of Texas System Β· Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11723635

Devices and methods for umbilical cord processing

The Board of Regents of the University of Texas System Β· Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11718612

Inhibitors of receptor interacting protein kinase I for the treatment of disease

The Board of Regents of the University of Texas System Β· Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11718589

Compositions and methods of modulating short-chain dehydrogenase

The Board of Regents of the University of Texas System Β· Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11713305

Zinc sensors for in vivo imaging of beta-cell function by MRI

The Board of Regents of the University of Texas System Β· Granted Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11713313

GLS1 inhibitors for treating disease

The Board of Regents of the University of Texas System Β· Granted Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted